Events & Resources

Learning Center
Read through guides, explore resource hubs, and sample our coverage.
Learn More
Events
Register for an upcoming webinar and track which industry events our analysts attend.
Learn More
Podcasts
Listen to our podcast, Behind the Numbers for the latest news and insights.
Learn More

About

Our Story
Learn more about our mission and how EMARKETER came to be.
Learn More
Our Clients
Key decision-makers share why they find EMARKETER so critical.
Learn More
Our People
Take a look into our corporate culture and view our open roles.
Join the Team
Our Methodology
Rigorous proprietary data vetting strips biases and produces superior insights.
Learn More
Newsroom
See our latest press releases, news articles or download our press kit.
Learn More
Contact Us
Speak to a member of our team to learn more about EMARKETER.
Contact Us

Walgreens’ downfall as a public company is more about its failed primary care investments than its pharmacy

The news: Walgreens is going private after being a publicly traded company for nearly 100 years. The retail pharmacy chain will be acquired by private equity firm Sycamore Partners for about $10 billion.

The total value of the transaction is $23.7 billion after accounting for debt and other liabilities, Walgreens said. The deal, which includes a 35-day window for Walgreens to solicit other offers, is expected to close in Q4 of this year.

Catch up quick: Sycamore has discussed splitting Walgreens into three parts and selling or spinning off some of the company’s assets, per the Financial Times. But the PE firm will probably keep Walgreens’ US-based retail pharmacy division, which accounted for over three-quarters of total 2024 sales.

You've read 0 of 2 free articles this month.

Get more articles - create your free account today!